← Open Payments lookup

SAMUEL KAUFMAN: Open Payments

NPI 1306326202 · RIVERSIDE, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,865 in 83 payments from 10 companies in 2025. Trend: 2023 $4,556 · 2024 $2,302 · 2025 $1,865

Food & beverage: $1,757Education: $108
CompanyPaymentsAmount
Axsome Therapeutics, Inc.14$347
Lundbeck LLC12$341
Otsuka America Pharmaceutical, Inc.13$226
Janssen Pharmaceuticals, Inc11$219
Teva Pharmaceuticals USA, Inc.7$217
E.R. Squibb & Sons, L.L.C.10$162
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$145
ABBVIE INC.5$109
Neurocrine BioSciences, Inc.2$57
Vanda Pharmaceuticals Inc.2$42

Products named: REXULTI, Auvelity, SPRAVATO, COBENFY, CAPLYTA, AUSTEDO XR, VRAYLAR, INGREZZA.

Industry payments across RI — which companies pay providers there.